Pulmonary Fibrosis

>

Latest News

Low Dose, Controlled Release Morphine Alleviates Cough in Idiopathic Pulmonary Fibrosis
Low Dose, Controlled Release Morphine Alleviates Cough in Idiopathic Pulmonary Fibrosis

January 21st 2024

These data suggest the promise of morphine for cough among those with idiopathic pulmonary fibrosis, though longer term research may be necessary.

Reviewing 2022 Advances in Childhood Interstitial Lung Disease and Non-CF Bronchiectasis
Reviewing 2022 Advances in Childhood Interstitial Lung Disease and Non-CF Bronchiectasis

July 26th 2023

FDA Accepts sNDA for Nintedanib in Pediatric Fibrosing Interstitial Lung Disease
FDA Accepts Nintedanib sNDA for Pediatric Fibrosing Interstitial Lung Disease

July 25th 2023

Ann Cameron, PhD: Increased Healthcare Burden in Patients with COPD
Ann Cameron, PhD: Increased Healthcare Burden in Patients with COPD

June 15th 2023

Nalbuphine ER Tablets Show Promise as Cough Therapy in Patients with IPF
Nalbuphine ER Tablets Show Promise as Cough Therapy in Patients with IPF

May 31st 2023

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.